Search and Filter
Results per Page:
Fred Hutch announces eight recipients of 2024 Dr. Eddie Méndez Scholar Award
National award recognizes exceptional postdoctoral researchers from historically underrepresented groups in science
Fred Hutch announces eight recipients of 2023 Dr. Eddie Méndez Scholar Award
In its fifth year, the national award recognizes exceptional postdoctoral researchers from groups who are historically underrepresented in science
Fred Hutch announces recipients of the 4th annual Dr. Eddie Méndez Award
Award honors postdoctoral researchers from underrepresented groups in science
Tip Sheet: Massive unmet needs in COVID-19 treatment, osteoporosis drugs for breast cancer, new bladder cancer target — and AIDS at 40
Summaries of recent Fred Hutch research findings and other news
Fred Hutch announces 12 recipients of Dr. Eddie Méndez award
In its third year, the annual award recognizes postdoctoral researchers from groups historically under-represented in science
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Fred Hutch announces 9 recipients of the Dr. Eddie Méndez award
The annual honor recognizes postdoctoral cancer biology researchers from underrepresented minority groups
Continuing a legacy
Ahmed Diab, an inaugural winner of the Dr. Eddie Méndez Award, remembers his mentor
Fred Hutch announces 7 inaugural recipients of Dr. Eddie Méndez award
The award recognizes postdoctoral researchers in cancer biology who are from underrepresented minority groups
Head and neck cancer cells are sensitive to WEE1 inhibition
From the Mendez Laboratory, Clinical Research Division
Stamping out bias with compassion and cartoons
Sikh Captain America visits the Hutch to talk storytelling, superheroes and strategies for fighting hate in life and at work
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Functional genomics pinpoints unique tumor vulnerabilities
Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA
AZD1775, a boost for platinum-based chemotherapy
From the Mendez Lab and Dr. Laura Chow, Clinical Research Division
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
$7 million grants boost functional genomics team science
Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology